Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Americas
The US Court of Appeals for the Federal Circuit has rejected a man’s claim that he was stopped from entering the fitness machine market because he feared infringing patents that were eventually found to be falsely attributed to Nautilus.   7 May 2015
Americas
The US Supreme Court has rejected pharmaceutical company Bristol-Myers Squibb’s appeal to review a ruling that found its patent covering a treatment for hepatitis B invalid.   6 May 2015
Americas
Law firm Fish & Richardson has added patent attorney Lisa Chiarini to its intellectual property litigation group.   5 May 2015
Big Pharma
The English High Court has ruled that a patent covering Novartis’s transdermal patch treatment for Alzheimer’s disease, Exelon, is invalid.   29 April 2015
Americas
A US court has ruled on how five claims in two patents related to acne drug Absorica should be construed, in a patent infringement case between Canada-based Cipher Pharmaceuticals and Actavis.   28 April 2015
Americas
The US Court of Appeals for the Federal Circuit has again found a patent covering a heart rate monitor to be valid, reversing and remanding a district court’s decision for further consideration in the long-running Biosig v Nautilus case.   28 April 2015
Americas
Hedge fund manager Kyle Bass and his Coalition for Affordable Drugs is continuing its campaign against certain pharmaceutical patents, most recently seeking to invalidate patents owned by Celgene and NPS Pharma.   27 April 2015
Americas
Japanese pharmaceutical company Hisamitsu and its US-based subsidiary Noven have sued Mylan for allegedly infringing two patents covering oestrogen patch Minivelle.   27 April 2015
Americas
Drug maker Shire, alongside two other companies, has sued Amneal Pharmaceuticals for allegedly infringing a patent related to Lialda, a drug for treating ulcerative colitis.   24 April 2015
Biotechnology
Biotechnology companies are concerned about the Dutch government’s plans to allow small plant breeders to develop new breeds while avoiding paying licensing fees, according to reports.   23 April 2015